Sale!

COL7A1 Gene Epidermolysis Bullosa Dystrophica Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The COL7A1 Gene Epidermolysis Bullosa Dystrophica Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the COL7A1 gene. These mutations are responsible for causing Dystrophic Epidermolysis Bullosa (DEB), a rare genetic skin disorder characterized by extreme fragility of the skin and mucous membranes, leading to blistering and scarring. The test, priced at 4400 AED, involves analyzing the patient’s DNA to detect any abnormalities in the COL7A1 gene, which plays a crucial role in the production of type VII collagen, a protein essential for skin strength and integrity. This genetic testing is vital for early diagnosis, guiding treatment options, and offering genetic counseling for affected families. By pinpointing the specific genetic alterations causing DEB, the test aids in understanding the severity of the condition, potential complications, and the risk of passing the disorder to future generations.

Description

COL7A1 Gene Epidermolysis bullosa dystrophica Genetic Test

Test Name: COL7A1 Gene Epidermolysis bullosa dystrophica Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Osteology Dermatology Immunology Disorders

Doctor: Dermatologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for COL7A1 Gene Epidermolysis bullosa dystrophica NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with COL7A1 Gene Epidermolysis bullosa dystrophica NGS Genetic DNA Test gene COL7A1

Test Details:

The COL7A1 gene is associated with a condition called epidermolysis bullosa dystrophica (EBD), which is a rare genetic disorder characterized by blistering and erosion of the skin and mucous membranes. EBD is caused by mutations in the COL7A1 gene, which provides instructions for making a protein called type VII collagen. This protein is essential for the formation and stability of the skin’s outermost layer, the epidermis.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of the COL7A1 gene. This test can identify specific mutations or variations in the gene that may be responsible for causing EBD. NGS technology allows for the simultaneous sequencing of multiple genes, providing a comprehensive analysis of the entire COL7A1 gene.

Genetic testing for EBD can help confirm a diagnosis, determine the specific genetic cause of the condition, and inform genetic counseling and management strategies. It can also be used for carrier testing in individuals with a family history of EBD to assess the risk of passing the condition on to their children.

It is important to note that genetic testing for EBD should be performed by a qualified healthcare professional or genetic counselor, who can interpret the results and provide appropriate guidance and support.

Test Name	COL7A1 Gene Epidermolysis bullosa dystrophica Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Osteology Dermatology Immunology Disorders
Doctor	Dermatologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for COL7A1 Gene Epidermolysis bullosa dystrophica NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with COL7A1 Gene Epidermolysis bullosa dystrophica NGS Genetic DNA Test gene COL7A1
Test Details	The COL7A1 gene is associated with a condition called epidermolysis bullosa dystrophica (EBD), which is a rare genetic disorder characterized by blistering and erosion of the skin and mucous membranes. EBD is caused by mutations in the COL7A1 gene, which provides instructions for making a protein called type VII collagen. This protein is essential for the formation and stability of the skin’s outermost layer, the epidermis. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of the COL7A1 gene. This test can identify specific mutations or variations in the gene that may be responsible for causing EBD. NGS technology allows for the simultaneous sequencing of multiple genes, providing a comprehensive analysis of the entire COL7A1 gene. Genetic testing for EBD can help confirm a diagnosis, determine the specific genetic cause of the condition, and inform genetic counseling and management strategies. It can also be used for carrier testing in individuals with a family history of EBD to assess the risk of passing the condition on to their children. It is important to note that genetic testing for EBD should be performed by a qualified healthcare professional or genetic counselor, who can interpret the results and provide appropriate guidance and support.